Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Tranwel 250
Tranwel 250 is a clinically proven antifibrinolytic medication that helps control excessive bleeding by stabilizing blood clots. It is widely used in menorrhagia, surgical bleeding, and trauma-related hemorrhage.
Uses of Tranwel 250
Manages heavy menstrual bleeding (menorrhagia).
Prevents excessive bleeding after surgery, dental procedures, or trauma.
Controls bleeding in patients with clotting disorders such as hemophilia.
Reduces the risk of hemorrhage in postpartum and post-operative conditions.
Benefits of Tranwel 250
Effectively controls abnormal bleeding in various conditions.
Prevents clot breakdown, ensuring stable clot formation.
Supports recovery after surgical procedures by minimizing blood loss.
Reduces menstrual blood flow without affecting hormone levels.
Mechanism of Action of Tranwel 250
Inhibits fibrinolysis by blocking plasminogen activation, preventing clot dissolution.
Stabilizes formed blood clots, reducing the risk of excessive bleeding.
Helps in hemostasis, ensuring effective blood clotting during injuries or surgeries.
Note: Tranwel 250 should be taken only under medical supervision. Patients with a history of blood clots should consult a doctor before use. Avoid taking it with anticoagulants unless prescribed.